The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Dr Francesc Bosch
Scientific Advisory Board Member
Professor Francesc Bosch is the Head of the Department of Hematology at the University Hospital Vall d’Hebron, Barcelona, ES, and a Professor in the Department of Medicine at Universitat Autònoma de Barcelona, Barcelona, ES.
He completed his medical degree in 1988 at Universitat de Barcelona, Barcelona, ES, after which he underwent postgraduate training in hematology at the Hospital Clinic of Barcelona, finishing in 1992. In 1998, Prof. Bosch was awarded his PhD by the Universitat de Barcelona — his thesis was titled ‘Cyclin D1 gene in chronic lymphoproliferative disorders’. From 1998 until 2000, Prof. Bosch undertook a postdoctoral research position at the Institute for Cancer Genetics, Columbia University, NY, US, after which he returned to Barcelona to continue researching chronic lymphocytic leukemia (CLL).
Prof. Bosch was made Head of the Department of Hematology at the University Hospital Vall d’Hebron, Barcelona, ES, in 2009, where his research focuses on the molecular pathogenesis of CLL and the development of novel therapeutic approaches. He has been involved in the development of clinical trials, currently as Chair of the Spanish Group of CLL (GELLC), which is responsible for the development of Spanish CLL trials. Besides this, he has published more than 100 papers in peer-reviewed journals, including the New England Journal of Medicine (NEJM), Nature Medicine, Blood and the Journal of Clinical Oncology, among others. He has also authored or co-authored a number of reviews and book chapters on the subject of CLL and other lymphoproliferative disorders.
Positions of responsibility/awards:
- Chair of the Spanish Group of CLL (GELLC)
- Principal Investigator of Vall d’Hebron Institute of Oncology’s Experimental Hematology Group since 2016
- Main organizer of the Young Investigator’s Group on CLL, 2007
- Member of the European Project for Mantle Cell Lymphoma, 1996
- Founder Member of the Grup d’Estudi dels Linfomes a Catalunya i Balears (GELCAB), 1996
- Young Investigator Award, Paris, from the European Hematology Association, 1996
- Young Investigator Award from the Catalan Society of Hematology and Hemotherapy, 1994
- Extraordinary Doctorate Award, 1998, for his PhD studies
Filter by content: